Circulating stromal cell-derived factor 1α levels in heart failure: A matter of proper sampling

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Baerts, Lesley ^a   Waumans, Yannick ^a   Brandt, Inger ^b   Jungraithmayr, Wolfgang ^c   Van Veken, Pieter Der ^a   Vanderheyden, Marc ^b   De Meester, Ingrid ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b OLV HOSPITAL   (Belgium)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMMUNOREACTIVITY; INCUBATION TEMPERATURE; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; N TERMINAL TRUNCATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN INDUCTION, SYNTHESIS AND MODIFICATION; SENSITIVITY AND SPECIFICITY; BLOOD; BLOOD ANALYSIS; HEMODYNAMICS; IMMUNOASSAY; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; PROTEIN DEGRADATION;

AGED; BLOOD CHEMICAL ANALYSIS; CHEMOKINE CXCL12; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HEART FAILURE; HEMODYNAMICS; HUMANS; IMMUNOASSAY; PROTEOLYSIS;

EID: 84952673810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141408     Document Type: Article

References (34)

1. Kanki S, Segers VFM, Wu W, Kakkar R, Gannon J, Sys SU, et al. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail. 2011; 4: 509-18. doi: 10.1161/ CIRCHEARTFAILURE.110.960302 PMID: 21606214
2. Subramanian S, Liu C, Aviv A, Ho JE, Courchesne P, Muntendam P, et al. Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk. Arterioscler Thromb Vasc Biol. 2014; 34: 2100-5. doi: 10.1161/ATVBAHA.114.303579 PMID: 25060794
3. Ghasemzadeh N, Hritani AW, De Staercke C, Eapen DJ, Veledar E, Al Kassem H, et al. Plasma Stromal Cell-Derived Factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease. Atherosclerosis. Elsevier; 2014.
4. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004; 110: 3300-5. PMID: 15533866
5. Lee B-C, Hsu H-C, Tseng W-YI, Chen C-Y, Lin H-J, Ho Y-L, et al. Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail. 2009; 11: 238-45. doi: 10.1093/eurjhf/hfn035 PMID: 19147447
6. Aiuti BA, Webb IJ, Bleul C, Springer T. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood. J Exp Med. 1997; 185: 111-120. PMID: 8996247
7. Yang T, Li Z-N, Chen G, Gu Q, Ni X-H, Zhao Z-H, et al. Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension. Heart Lung. 43: 322-7. doi: 10.1016/j.hrtlng.2014.04.016 PMID: 24856224
8. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001; 250: 91-104. PMID: 11489059
9. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1997; 16: 6996-7007. PMID: 9384579
10. Shioda T, Kato H. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. PNAS. 1998; 95: 6331-6336. PMID: 9600965
11. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004; 305: 1000-3. PMID: 15310902
12. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001; 276: 43503-8. PMID: 11571304
13. Delgado MB, Clark-Lewis I, Loetscher P, Langen H, Thelen M, Baggiolini M, et al. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol. 2001; 31: 699-707. PMID: 11241273
14. Valenzuela-Fernández A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D, et al. Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem. 2002; 277: 15677-89. PMID: 11867624
15. Jungraithmayr W, De Meester I, Matheeussen V, Baerts L, Arni S, Weder W. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemiareperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg. 2012; 41: 1166-73. doi: 10. 1093/ejcts/ezr180 PMID: 22219460
16. Zaruba M-M, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell. 2009; 4: 313-23. doi: 10.1016/j.stem.2009.02.013 PMID: 19341621
17. Larocca TJ, Jeong D, Kohlbrenner E, Lee A, Chen J, Hajjar RJ, et al. CXCR4 gene transfer prevents pressure overload induced heart failure. J Mol Cell Cardiol. 2012; 53: 223-32. doi: 10.1016/j.yjmcc. 2012.05.016 PMID: 22668785
18. Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013; 112: 816-25. doi: 10.1161/CIRCRESAHA. 111.300440 PMID: 23429605
19. Shigeta T, Aoyama M, Bando YK, Monji A, Mitsui T, Takatsu M, et al. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions. Circulation. 2012; 126: 1838-51. doi: 10.1161/CIRCULATIONAHA.112.096479 PMID: 23035207
20. Dos Santos L, Salles TA, Arruda-Junior DF, Campos LCG, Pereira AC, Barreto ALT, et al. Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure. Circ Heart Fail. 2013; 6: 1029-38. doi: 10.1161/CIRCHEARTFAILURE.112.000057 PMID: 23894014
21. De Meester I, Vanhoof G, Lambeir AM, Scharpé S. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). J Immunol Methods. 1996; 189: 99-105. PMID: 8576585
22. Lambeir a M, Proost P, Durinx C, Bal G, Senten K, Augustyns K, et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem. 2001; 276: 29839-45. PMID: 11390394
23. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128: e240-327. doi: 10.1161/ CIR.0b013e31829e8776 PMID: 23741058
24. Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation. 1999; 99: 3009-16. PMID: 10368118
25. Matheeussen V, Baerts L, De Meyer G, De Keulenaer G, Van der Veken P, Augustyns K, et al. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biol Chem. 2011; 392: 189-98. doi: 10.1515/BC.2011.002 PMID: 21194356
26. Pala L, Pezzatini A, Dicembrini I, Ciani S, Gelmini S, Vannelli BG, et al. Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. Acta Diabetol. 2012; 49 Suppl 1: S59-63. doi: 10.1007/s00592-010-0195-3 PMID: 20455069
27. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood. 2006; 108: 1602-10. PMID: 16670267
28. Fadini GP, Boscaro E, Albiero M, Menegazzo L, Frison V, de Kreutzenberg S, et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care. 2010; 33: 1607-9. doi: 10. 2337/dc10-0187 PMID: 20357375
29. Huang C-Y, Shih C-M, Tsao N-W, Lin Y-W, Huang P-H, Wu S-C, et al. Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells. Br J Pharmacol. 2012; 167: 1506-19. doi: 10.1111/j.1476-5381.2012.02102.x PMID: 22788747
30. Segers VFM, Lee RT. Protein therapeutics for cardiac regeneration after myocardial infarction. J Cardiovasc Transl Res. 2010; 3: 469-77. doi: 10.1007/s12265-010-9207-5 PMID: 20607468
31. Chung ES, Miller L, Patel AN, Anderson RD, Mendelsohn FO, Traverse J, et al. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial. Eur Heart J. 2015; 36: 2228-38. doi: 10.1093/eurheartj/ehv254 PMID: 26056125
32. Theiss HD, Gross L, Vallaster M, David R, Brunner S, Brenner C, et al. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. Int J Cardiol. 2013; 168: 3359-69. doi: 10.1016/j.ijcard.2013.04.121 PMID: 23669105
33. Mortier A, Van Damme J, Proost P. Regulation of chemokine activity by posttranslational modification. Pharmacol Ther. 2008; 120: 197-217. doi: 10.1016/j.pharmthera.2008.08.006 PMID: 18793669
34. Pyo RT, Sui J, Dhume A, Palomeque J, Blaxall BC, Diaz G, et al. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol. 2006; 41: 834-44. PMID: 17010372